MedTrace Logo

Randomized Controlled Study of Comparing Follitrope Versus Gonal-f in Chinese Infertility Women.

NCT03506243 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 451

Last updated 2018-04-24

No results posted yet for this study

Summary

This study is for evaluating safety and efficacy of Recombinant human follicle-stimulating hormone (Follitrope) injection compared with Gonal-F® Pen undergoing controlled ovarian hyper stimulation in vitro fertilization - embryo transfer (IVF-ET) in China

Conditions

  • Infertility, Female

Interventions

BIOLOGICAL

Follitrope PFS

Follitrope PFS

BIOLOGICAL

Gonal-f pen

Gonal-f pen

Sponsors & Collaborators

  • LG Chem

    collaborator INDUSTRY

  • Hangzhou YuYuan Bioscience Technology Co., Ltd.

    lead OTHER

Principal Investigators

  • Ying Pu Sun · The First Affiliated Hospital of Zhengzhou University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-09-30
Completion
2017-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03506243 on ClinicalTrials.gov